Pyruvate kinase M2, but not M1, allele maintains immature metabolic states of murine embryonic stem cells.

Authors:
Konno M; Ishii H; Koseki J; Tanuma N; Nishida N and 12 more

Journal:
Regen Ther

Publication Year: 2015

DOI:
10.1016/j.reth.2015.01.001

PMCID:
PMC6581773

PMID:
31245442

Journal Information

Full Title: Regen Ther

Abbreviation: Regen Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors have no conflict of interest to declare."

Evidence found in paper:

"We thank the members of our laboratory for useful advice. We also thank Dr. Boudewijn MT Burgering (University Medical Center Utrecht, The Netherlands) for the p300 and FOXO mutant vectors. This study was financially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (#23390199, #25112708, #25134711, #30253420, #26670604) (MK, HI, MM); a Grant-in-Aid from the Ministry of Health, Labor, and Welfare (#H23-003) (MK, HI, MM); grants from National Institute of Biomedical Innovation (#12-4) (MK, HI, MM) and Osaka University Drug Discovery Funds, Japan (MK, HI, MM); grants from the Kobayashi Cancer Research Foundation (HI), Princess Takamatsu Cancer Research Fund (HI), Takeda Science and Medical Research Foundation (HI), Suzuken Memorial Foundation (MK), Yasuda Medical Foundation (NN), and Pancreas Research Foundation of Japan (KK). MK and HI received partial support from Chugai Co., Ltd., Yakult Honsha Co., Ltd., through institutional endowments. HI received partial support from Merck Co., Ltd., Unitech Co., Ltd., EBM Research Center Inc., and Taiho Therapeutic Co., Ltd. through institutional endowments; those funders had no role in main experimental equipments, supplies expenses, study design, data collection and analysis, decision to publish, or preparation of the manuscript, in this work."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025